Legal Representation
Attorney
Evan A. Raynes
USPTO Deadlines
Next Deadline
29 days remaining
NOA E-Mailed - SOU Required
Due Date
February 22, 2026
Extension Available
Until August 22, 2026
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 18, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 18, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 18, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 13, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 13, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 16, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 16, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 22, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 24, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 24, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 24, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 24, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 24, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 24, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 11, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
Class 005
Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only
Class 042
Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Classification
International Classes
001
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"